Please Subscribe to get a daily link to Pat's blog via email

Subscribe!

Your privacy is important to us. We will never spam you and keep your personal data secure.

secondary cancers

Home/Tag:secondary cancers
4 09, 2012

The million dollar question: How long do I need to stay on maintenance therapy?

Tags: , , , , |16 Comments

"My myeloma is stable.  How long do I need to stay on maintenance therapy?" This is the million dollar question for nearly all multiple myeloma patients at some time during their myeloma journey. More and more articles like the one below nudge us toward the decision to stay on maintenance indefinitely.  Give it a quick

12 05, 2012

More about Revlimid and secondary cancer risk

Tags: , , , , , , , |20 Comments

Concerned about FDA secondary cancer warnings when using Revlimid? Dr. James Berenson helps patients understand a new FDA investigation regarding the use of lenalidomide (Revlimid) and thalidomide in a timely interview by Patient Power founder and host, Andrew Schorr. Dr. Berenson also comments on a new study from Sweden regarding increased risk of blood clots

25 03, 2012

Lots of myeloma related odds ‘n ends continued…

Tags: , , , , , |0 Comments

More odds and ends to share... One of our regular readers and contributors named Mark, passed-along these helpful suggestions after learning I was having issues with nausea again. Pat, Sorry to hear of your digestive issues.  Have you tried using Culturelle Lactobacillus?  I am on a Study using it and I think it works.  The

23 12, 2011

As multiple myeloma patients live longer, secondary cancer risks need to be addressed…

Tags: , , , , , , |0 Comments

Yesterday I asked if this secondary cancer issue "is much to do about nothing, or something that concerns you enough to keep you up at night?" Based on the response, I have to conclude the answer is "NO!" I understand that this isn't a very pleasant topic to be discussing right before Christmas.  We can

22 12, 2011

Should multiple myeloma patients fear secondary cancer risk?

Tags: , , , , , , , |6 Comments

The risk of developing a secondary cancer following years of ongoing treatment was a red-hot issue one year ago. Why?  A clinical study--presented at last year's ASH meetings in Orlando--showed multiple myeloma patients have an 8% risk of developing a secondary cancer if they use Revlimid maintenance following a stem cell transplant. The day following

9 06, 2011

ASCO Odds/Ends And Clinical Study Links

Tags: , , , , , , , , , , |0 Comments

A few more quick notes from ASCO before the first of a long running series about ways to improve peripheral neuropathy (PN) starts later today: Secondary Cancer Risk From Using Revlimid: Based on the results of this retrospective analysis, Dr. Palumbo concluded that Revlimid ,when used with melphalan, increases the rate of secondary cancers.  The

11 05, 2011

Long Term Tylenol (Acetaminophen) Use Doubles Risk Of Blood Cancer In Adults Over 50 Years Old

Tags: , , , |4 Comments

This is not good news, especially for someone like me who takes a lot of Tylenol everyday to help mute my bone pain and peripheral neuropathy symptoms:Acetaminophen linked to cancer: How big is the threat? - CBS NewsSimply click-on the headline link above to read the article.  This is the type of story I usually run on two of

2 04, 2011

This Is Very Rare: Reader Reports A Friend Has Been Diagnosed With Waldenstrom’s Macroglobulinemia AND Multiple Myeloma…

Tags: , , |0 Comments

Here is a link back to an article I wrote today on my HelpWithCancer.org site, about one of our regular readers who has a type of lymphoma called Waldenstrom's Macroglobulinemia:An Inside Look At A Rare Form Of Lymphoma,Waldenstrom's Macroglobulinemia.Doesn't this slide look a lot like multiple myeloma?The reader,Peter, is studying-up on multiple myeloma because he has

20 02, 2011

The IMF and International Myeloma Working Group Agree: No Evidence Long Term Use Of Revlimid Causes Secondary Cancer In Patients Who Have Not Undergone Stem Cell Transplantation

Tags: , , , |3 Comments

Friday I wrote an article about the International Myeloma Foundation's (IMF) response to the new Revlimid/secondary cancer controversy:  The International Myeloma Foundation's Official Statement Concerning Data Linking Long Term/Post Transplant Revlimid Use To Secondary Cancers.While I was preparing the article, I corresponded several times with Robin Touhy, Regional Director of Support Groups for the IMF's

18 02, 2011

The International Myeloma Foundation’s Official Statement Concerning Data Linking Long Term/Post Transplant Revlimid Use To Secondary Cancers

Tags: , , , , , |1 Comment

Wednesday, the International Myeloma Foundation (IMF) hosted a private conference call.The call featured Dr. Brian G.M. Durie, of Cedar Sinai Cancer Center, and Dr. Ken Anderson, of the Dana Farber Cancer Institute, who offered their personal views on the issue of Second Primary Cancers in the ongoing treatment of multiple myeloma in a private conference call to

19 01, 2011

Dr. Barlogie From UAMS: "Revlimid Does Not Cause Secondary Cancer."

Tags: , , , , , |0 Comments

There was a very large controversy last December at ASH in Orlando.  Two studies which followed long-term Revlimid users found they had an 8% risk of developing a form of Acute Myeloid Leukemia (AML).Revlimid is manufactured by Celgene Pharmaceuticals, a publicly traded company.  This news caused Celgene's stock to crash and rumors to explode in

28 12, 2010

Was Controversy About Secondary Cancer Risk Among Long Term Revlimid Users Reactionary Or Overblown?

Tags: , , , , , |3 Comments

A fellow multiple myeloma patient blogger and good friend, Nick van Dyk, shared his views about the recent secondary cancer scare for long term users of Revlimid today:  Some thoughts on this Revlimid situation...perhaps a false alarm?Nick lives in California, yet he travels all of the way to Arkansas to see myeloma specialists at UAMS.